Multicenter Evaluation of Docetaxel, Gemcitabine, and Bevacizumab Combination Followed by Bevacizumab Alone in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

PHASE2TerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions

Non-small Cell Lung Cancer

Interventions

DRUG

docetaxel

DRUG

gemcitabine

DRUG

bevacizumab

Trial Locations (1)

Sanofi-Aventis Administrative Office, Bridgewater